Entod Pharmaceuticals denies making false claims about their new PresVu eye drops and plans to challenge the suspension by the Drugs Controller General of India of its manufacturing and sales ...
The drug regulator revoked the marketing and manufacturing licences granted to drug maker Entod Pharmaceuticals citing ‘unauthorised promotion’ and concerns over the ‘unsafe use’ of the eye drops by ...
In a statement, the company said, “Our approval by DCGI was based on a valid controlled clinical trial in 234 patients which was successful in showing efficacy and safety of these eye drops in ...
PresVu eye drops, developed by Entod Pharmaceuticals, were launched with considerable media attention earlier this month as a novel solution for presbyopia. Presbyopia is a condition where ...
Following last week’s controversy over Mumbai-based pharmaceutical company ENTOD Pharmaceutical’s claims that its eye drops could lead to reading glasses not being needed for presbyopia ...
India's drug regulator has suspended the permission granted to manufacture and sell their new eye drops, PresVu, which claimed to remove reading glasses. Listen to Story India's drug regulator has ...
Researchers in China and the UK believe they may have found an unusual solution that doesn’t involve eye drops — laughter. Dry eye syndrome can be a complex disease with symptoms ranging from ...
The major attraction of the new season is the epic clash between the Evolutions of two Clash Royale tanks. While P.E.K.K.A. Evolution already launched at the start of Season 63, the evolved ...
Laughter may be as effective as eye drops in improving symptoms of dry eye disease, finds a clinical trial from China published by The BMJ today The researchers suggest that laughter exercise ...
ENTOD Pharmaceuticals has recently launched PresVu eye drops, which have been approved by the Drug Controller General of India (DCGI). Marketed as a potential breakthrough for presbyopia — a ...
Also Read | All about pilocarpine, the compound used in DCGI-approved eye drops that promises to replace reading glasses The company also said that PresVu uses “advanced dynamic buffer technology” — ...
Credit: Formosa Pharmaceuticals Inc. Formosa Pharmaceuticals has announced the first shipment of its ophthalmic asset, clobetasol propionate ophthalmic suspension 0.05% (APP13007),to the US to ...